Nunzia Pharmaceutical

NUNZ · OTC

$0.0001+$0.0001 (+0.00%)TodayMarket closed · Oct 15, 9:30 AM ET

No price history for this range.

About NUNZ

Nunzia Pharmaceutical Corp. engages in the manufacture and sales of drugs. The company is headquartered in Long Beach, California. The firm focuses on development and delivery of pharmaceutical and nutraceutical-based therapies for the behavioral symptoms of Autistic Spectrum of Disorders (ASDs) and related conditions, such as Fragile X syndrome, as well as common anxiety-based disorders. The firm has developed NUNZIA, which is a combination of 16 vitamins, minerals and herbs which directly focuses and targets the hippocampus area of the brain, where all anxiety-based disorders originate.

Employees: 0
Headquarters: Long Beach, California
Listed: Jan 23, 1995
Sector: Consumer Staples
Industry: Personal Care Products
Website: vcgi.com

Leadership

Nunzia Pharmaceutical executives
Name	Title	Since	Age
R. Steve Mills	—	2005	54
Kingman Hitz	—	2005	61
Roger Kron	—	2005	48
G.David Henry	—	—	62
Mary Pohlmeier	—	—	61
Robin Sandifer	—	—	72

Similar companies

Companies in the same industry as Nunzia Pharmaceutical

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.